HPV testing to become cheaper, more accessible in the Americas

The Pan American Health Organization and Unitaid have reached an agreement to significantly reduce the cost of HPV molecular testing in Latin America and the Caribbean. This initiative aims to improve access to cervical cancer screening and support the WHO's global goal of eliminating the disease.
Why it matters
Lowering the cost of diagnostic technology is a critical step in reducing health disparities and mortality rates in developing regions.
Share Copied to clipboard VCU CNS/Flick cc Although more than 40,000 women in Latin America and the Caribbean die of cervical cancer every year, many countries in the region have struggled with the cost of screening for the virus that causes the disease, human papillomavirus (HPV).
Now, high-quality screening tests will become more affordable because of an agreement between the Pan American Health Organization (PAHO), part of the World Health Organization (WHO) and Unitaid, an international aid group. Participating countries will save 30% to 70% on the cost of molecular tests for HPV, according to a press release from the two groups.
In addition to access to testing, countries will receive implementation support, equipment, training, maintenance, and technical assistance to help scale up HPV testing.
Get smarter about the news
Sign up free for a feed built around what you actually care about, Dive Deeper research on any story, and the full text of every article.
Create free accountAlready have an account? Sign in